200 related articles for article (PubMed ID: 31917969)
21. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
[TBL] [Abstract][Full Text] [Related]
22. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Sarzotti-Kelsoe M; Bailer RT; Turk E; Lin CL; Bilska M; Greene KM; Gao H; Todd CA; Ozaki DA; Seaman MS; Mascola JR; Montefiori DC
J Immunol Methods; 2014 Jul; 409():131-46. PubMed ID: 24291345
[TBL] [Abstract][Full Text] [Related]
23. Broadly neutralizing antibodies for HIV-1 prevention and therapy.
Julg B; Barouch D
Semin Immunol; 2021 Jan; 51():101475. PubMed ID: 33858765
[TBL] [Abstract][Full Text] [Related]
24. Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope.
van Dorsten RT; Lambson BE; Wibmer CK; Weinberg MS; Moore PL; Morris L
J Virol; 2020 Jan; 94(2):. PubMed ID: 31619559
[TBL] [Abstract][Full Text] [Related]
25. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
Morgand M; Bouvin-Pley M; Plantier JC; Moreau A; Alessandri E; Simon F; Pace CS; Pancera M; Ho DD; Poignard P; Bjorkman PJ; Mouquet H; Nussenzweig MC; Kwong PD; Baty D; Chames P; Braibant M; Barin F
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):237-45. PubMed ID: 26413851
[TBL] [Abstract][Full Text] [Related]
26. Broadly neutralizing antibodies against HIV-1 and concepts for application.
Gruell H; Schommers P
Curr Opin Virol; 2022 Jun; 54():101211. PubMed ID: 35306354
[TBL] [Abstract][Full Text] [Related]
27. International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.
Ozaki DA; Gao H; Todd CA; Greene KM; Montefiori DC; Sarzotti-Kelsoe M
PLoS One; 2012; 7(1):e30963. PubMed ID: 22303476
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
Stefic K; Bouvin-Pley M; Essat A; Visdeloup C; Moreau A; Goujard C; Chaix ML; Braibant M; Meyer L; Barin F
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404804
[TBL] [Abstract][Full Text] [Related]
29. Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques.
Rosenberg YJ; Lewis GK; Montefiori DC; LaBranche CC; Lewis MG; Urban LA; Lees JP; Mao L; Jiang X
PLoS One; 2019; 14(2):e0212649. PubMed ID: 30785963
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.
Freund NT; Wang H; Scharf L; Nogueira L; Horwitz JA; Bar-On Y; Golijanin J; Sievers SA; Sok D; Cai H; Cesar Lorenzi JC; Halper-Stromberg A; Toth I; Piechocka-Trocha A; Gristick HB; van Gils MJ; Sanders RW; Wang LX; Seaman MS; Burton DR; Gazumyan A; Walker BD; West AP; Bjorkman PJ; Nussenzweig MC
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100831
[TBL] [Abstract][Full Text] [Related]
31. Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice.
van der Velden YU; Villaudy J; Siteur-van Rijnstra E; van der Linden CA; Frankin E; Weijer K; Schermer E; Vink MA; Berkhout B; Sanders RW; van Gils MJ
AIDS Res Hum Retroviruses; 2018 Sep; 34(9):790-793. PubMed ID: 30003812
[TBL] [Abstract][Full Text] [Related]
32. Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure.
Umotoy JC; de Taeye SW
Front Immunol; 2021; 12():708806. PubMed ID: 34276704
[TBL] [Abstract][Full Text] [Related]
33. Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
Mesa KA; Yu B; Wrin T; Petropoulos CJ; Pogson GH; Alexander DL; Perez G; O'Rourke SM; Sinangil F; Robinson J; Conant MA; Berman PW
PLoS One; 2019; 14(4):e0213409. PubMed ID: 30969970
[TBL] [Abstract][Full Text] [Related]
34. Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1.
Moshoette T; Ali SA; Papathanasopoulos MA; Killick MA
Retrovirology; 2019 Nov; 16(1):31. PubMed ID: 31703699
[TBL] [Abstract][Full Text] [Related]
35. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
36. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
[TBL] [Abstract][Full Text] [Related]
37. Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry.
Khan SN; Sok D; Tran K; Movsesyan A; Dubrovskaya V; Burton DR; Wyatt RT
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976677
[TBL] [Abstract][Full Text] [Related]
38. New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment.
Gama L; Koup RA
Annu Rev Med; 2018 Jan; 69():409-419. PubMed ID: 29029583
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing antibodies for HIV-1 prevention.
Julg B; Barouch DH
Curr Opin HIV AIDS; 2019 Jul; 14(4):318-324. PubMed ID: 31082819
[TBL] [Abstract][Full Text] [Related]
40. [The affinity maturation, characteristics and application of HIV-1 broadly neutralizing antibodies].
Wan XR; Sun M; Li Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):225-232. PubMed ID: 35184454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
